- For US Healthcare Professionals Only
- Important Safety Information
- Full Prescribing Information
- INVEGA HAFYERA™ Consumer Site
INVEGA HAFYERA™ Offers Fewer Doses for a Life Less Defined by Their Schizophrenia Treatment1
Start INVEGA SUSTENNA® Earlier in the Treatment Journey to Put Patients on a Path to Just 2 Doses a Year
- Must be adequately treated for at least 4 months with INVEGA SUSTENNA® to transition to INVEGA HAFYERA™
- It is recommended that the last 2 doses of INVEGA SUSTENNA® be the same strength (156 mg or 234 mg) before starting INVEGA HAFYERA™.
- Must be adequately treated for at least 4 months with INVEGA SUSTENNA® to transition to INVEGA TRINZA®
- Must be adequately treated with at least one 3-month injection cycle of INVEGA TRINZA® at doses of 546 mg or 819 mg to transition to INVEGA HAFYERA™
A Seamless Dosing Pathway to INVEGA HAFYERA™
- INVEGA HAFYERA™ is to be used only after adequate treatment has been established with INVEGA SUSTENNA® for at least 4 months (with the last 2 doses being 156 mg or 234 mg), or INVEGA TRINZA® for at least one 3-month injection cycle (at doses of 546 mg or 819 mg)
- There are no equivalent doses of INVEGA HAFYERA™ for the 39 mg, 78 mg, or 117 mg doses of INVEGA SUSTENNA®, which were not studied
- There are no equivalent doses of INVEGA HAFYERA™ for the 273 mg or 410 mg doses of INVEGA TRINZA®, which were not studied
REFERENCE: 1. INVEGA HAFYERA™ [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; August 2021.
For patients being treated with oral antipsychotics, start their journey to INVEGA HAFYERA™ by initiating treatment with INVEGA SUSTENNA®